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Abstract. Breast chondrosarcoma is a rare sarcoma that 
mainly occurs in females >50 years old. To the best of our 
knowledge, only 16 cases were reported in the literature 
prior to 2013 and all patients were surgically treated by 
mastectomy, with or without lymphadenectomy, which 
was occasionally preceded by neoadjuvant chemotherapy. 
However, the literature does not report the benefit of mastec-
tomy compared with a more conservative surgery. The 
present study reports a novel case of extraskeletal chondro-
sarcoma of the breast. A 63-year-old female patient presented 
with a neoplasm localized in the upper-outer quadrant of 
the right breast. The palpable lesion with sharp margins 
was a firm parenchymatous mass, which was confirmed by 
ultrasonography and mammography. The patient under-
went conservative quadrantectomy instead of mastectomy, 
followed by post-surgical chemotherapy. A positron emission 
tomography scan performed five months subsequent to the 
surgery revealed no remnants of the disease. The patient 
underwent a strict clinical and instrumental follow-up, and 
two and half years after surgery, there are no signs of recur-
rent disease. In conclusion, the present case is currently one 
of the two cases in which a more conservative quadrantec-
tomy was performed, instead of mastectomy. This surgical 
approach did not lead to metastasis and resulted in a good 
follow-up for the patient.
Introduction
Sarcomas are tumors that rarely occur in the breast, 
accounting for 0.5-1% of all breast cancers (1). Sarcomas 
arise from the stromal tissue of the mammary gland and 
if angiosarcoma, which has a more severe prognosis, is 
excluded, the course of the disease is not significantly 
different compared with tumors arising from other sites (2). 
Chondrosarcoma is a rare type of sarcoma that, to the best 
of our knowledge, was reported in only five cases in the 
literature prior to 2001 (3-6) and 11 cases in the literature 
between 2002 and 2013 (7-17), and mainly occurs in females 
>50 years old. Macroscopically, chondrosarcoma appears 
as a whitish-gray, round mass with regular margins and 
necrotic, hemorrhagic or cystic areas that is characterized by 
rapid growth, although the sarcoma rarely invades locally or 
metastasizes to lymph nodes (9-13,18,19). Chondrosarcoma 
is microscopically characterized by chondroid lacunae, in 
which numerous chondroblasts exhibit hyperchromatic 
nuclei and the absence of epithelial areas or other stromal 
components, with a high mitotic division rate. There is also 
an absence of estrogen, androgen or HER2 receptors, with 
a strong expression of the S100 protein, cytokeratin and the 
membrane epithelial antigen (1). Ultrasonography reveals a 
hyperechogenic formation, with a polylobated shape, while 
mammography exhibits a round hyperdense mass with 
regular margins, which may simulate a benign lesion (20). 
The differential diagnosis of chondrosarcoma is usually 
between malignant phyllodes tumor (PT), metaplastic 
carcinoma (MC), in which a significant percentage of meta-
plastic elements (>10%) are present, and matrix-producing 
metaplastic carcinoma (MP-MC), a rare cancer of the 
breast characterized by osteoid and chondral matrices 
and the presence of carcinomatous features (20,21). The 
mainstay of treatment for sarcoma of the breast, as with 
sarcomas at other sites, is a surgical procedure combined 
with mastectomy (20). The present study describes a novel 
case of extraskeletal chondrosarcoma of the breast that was 
treated with a more conservative surgical treatment instead 
of mastectomy, as an innovative surgical approach. Written 
informed consent was obtained from the patient.
Case report
A 63-year-old female presented to Umberto I Hospital, 
Sapienza University (Rome, Italy) with a neoplasm local-
ized in the upper-outer quadrant of the right breast (RUO). 
The palpable lesion was a firm parenchymatous mass that 
was mobile on the superficial and deep planes, exhibited 
Rare chondrosarcoma of the breast treated with 
quadrantectomy instead of mastectomy: A case report
VITTORIO PASTA,  DANIELA SOTTILE,  PAOLO URCIUOLI,  
LUCA DEL VECCHIO,  FILIPPO CUSTURERI  and  VALERIO D'ORAZI
Department of Surgical Sciences, Sapienza University, Rome I-00161, Italy
Received April 11, 2014;  Accepted November 13, 2014
DOI: 10.3892/ol.2014.2803
Correspondence to: Professor Valerio D'Orazi, Department of 
Surgical Sciences, Sapienza University, 324 Viale Regina Elena, 
Rome I-00161, Italy
E-mail: info@valeriodorazi.com
Key words: chondrosarcoma, sarcoma, breast, surgery, mastectomy
PASTA et al:  RARE CHONDROSARCOMA TREATED WITH QUADRANTECTOMY 1117
sharp margins and a poor homogeneous surface and was not 
painful. There was no evident axillary lymphadenopathy. 
An X-ray mammogram revealed the enhancement of a 
previously observed opacity in the superolateral quadrant, 
with partial sharp margins. Using core biopsy, the mass was 
determined to be a mammary parenchyma in continuity with 
hypercellular condroid tissue, with the presence of atypical, 
occasionally polynuclear elements, and rare mitosis. Ultra-
sonography revealed the presence of a hypoechoic, solid 
neoformation with jagged edges and a maximum diameter 
of ~3 cm (Fig. 1). Mammography revealed an upper-outer 
para-areolar oval opacity with partially shaded contours that 
demonstrated the presence of an adequate margin of healthy 
perilesional tissue (Fig. 2). The formation was delimited and 
split by fibrous stroma, in which ductal structures and ectatic 
vessels were present. The tumor appeared to be a malignant 
mesenchymal neoplasm with chondroid differentiation, 
although it could not be excluded that the formation was a 
component of a biphasic lesion similar to phyllodes tumors. 
Considering the size of the lesion, the overall dimensions 
of the breast and the lack of literature reporting a genuine 
benefit of mastectomy compared with more conservative 
surgery (Table I), it was decided to refer the patient for a 
wide RUO quadrantectomy, to include any skip metastasis. 
For an improved examination, tissue samples of the resection 
margins were separately analyzed by a pathologist.
Histopathological results. The gross post-surgical 
examination revealed a mammary-parenchymal section, 
6.5x4.5x5 cm in size, covered by 4.1 cm of skin. Following 
the cut, a round-shaped neoplasm was observed, possessing 
a maximum diameter of 3 cm and exhibiting gelatinous 
and tense-elastic regions. The biopsy specimen from the 
neoplasm revealed the proliferation of mesenchymal cells 
with round nuclei, eosinophilic cytoplasm and ill‑defined 
boundaries. The neoplastic elements were arranged in groups 
of varying sizes, in the context of a layer with a basophilic 
myxoid appearance. A chondroid-type layer was present at 
Figure 1. Ultrasonography of the tumor mass. The image reveals the presence of a hypoechoic solid neoformation with jagged edges and a maximum diameter 
of ~3 cm.
Figure 2. Mammography of the right breast. The images reveal upper-outer para-areolar oval opacity with partially shaded contours, and an adequate margin 
of healthy perilesional tissue.
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the periphery of the lesion, with a star-shaped appearance 
and pleomorphic nuclei. Certain figures were suggestive of 
invasion, however, no perilesional venous vessel invasion 
was detected. The mitotic index was seven out of 10 fields 
of high magnification. The tumor possessed large areas 
of necrosis. The neoplastic elements exhibited 50% of the 
proliferation index, as evaluated by Ki-67 staining. The 
remaining parenchyma demonstrated a nodular lesion with 
a diameter of 1.2 cm attributable to stromal fibrosis, in the 
absence of further significant atypia. All resection margins 
were separately analyzed by a pathologist and were found 
to be free from cancer-associated elements. A diagnosis of 
chondrosarcoma of the breast was finally made.
Post‑surgical treatments. Subsequent to surgery there was a 
discussion between the various consulted oncologists on the 
necessity of further treatments, as the role of chemotherapy 
and radiotherapy in primary breast chondrosarcoma is unre-
solved (1). Despite the possibility that adjuvant therapy may 
decrease the rates of local and systematic recurrence, the 
literature is lacking in significant information regarding the 
benefit of post‑surgery chemo‑ or radiotherapy in the face of 
the side-effects of those therapies, due to the rarity of this 
disease and the small number of cases reported (1). It was 
decided, with the consent of the patient, to administer five 
cycles of standard radiotherapy on the residual breast tissue 
(50 Gy) and operative site (10 Gy), used only as a complement 
to radical surgery, and six cycles of precautionary chemo-
therapy for six weeks, with epirubicin (120 mg per cycle) and 
ifosfamide (2,950 mg per cycle), as previously reported (1). A 
positron emission tomography scan performed five months 
after the surgery excluded the presence of remnants of the 
disease (Fig. 3). Therefore, whilst the patient continues to 
undergo a strict clinical and instrumental follow-up two 
and half years after surgery, there are no signs of recurrent 
disease.
Discussion
The present study describes a novel case of extraskeletal 
chondrosarcoma of the breast that was treated with a more 
conservative quadrantectomy instead of mastectomy, as an 
innovative surgical approach. The benefit of performing 
quadrantectomy instead of mastectomy is not addressed in 
the literature (1,2). Between 1967 and 2001, only five cases of 
chondrosarcoma of the breast were reported in the literature, 
and all were treated with mastectomy (3-6). The present review 
revealed that between 2001 and 2013 only 11 other cases 
were described, as summarized in Table I. All the 16 studies, 
consisting of 15 female patients and one male patient, reported 
mastectomy as the surgical treatment choice. In four cases 
mastectomy was associated with lymphadenectomy and in 
one case mastectomy was preceded by neoadjuvant chemo-
therapy (Table I). The choice of mastectomy was dictated not 
only by a strictly local situation of the lesion, but also by the 
lack of previous studies, due to the rarity of the lesion, and by 
an old interpretation of the surgical approach to sarcoma at 
this particular site. 
Although surgery remains the gold standard for the treat-
ment of breast sarcoma, and chondrosarcoma in particular (1), 
Figure 3. Positron emission tomography examination performed approximately five months after surgery, through which the presence of recurrence was 
excluded.
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there is no uniformity of view on the most effective type of 
surgery that may justify the requirement for radical interven-
tion, such as mastectomy, compared to surgery with wide 
tumor-free margins (20). According to a study performed by 
Zelek et al (22), and another previous study (23), mastectomy 
for sarcomatous malignancy should not be associated with 
axillary lymphadenectomy, as the sarcoma does not exhibit 
a tendency to spread through lymphatic system, but mainly 
through the haematogenous route. Furthermore, the lymph-
ectomy exposes the patient to greater morbidity without a 
real benefit in terms of disease‑free and overall survival (20). 
Thus, lymphectomy should be indicated only if the lesion is 
associated with an epithelial component or when all breast 
quadrants are involved, in particular the upper-outer (supero-
lateral) quadrants (20). 
In previous years, the surgical approach to all sarcomas, 
and in particular to those of the breast, has been reevaluated 
as it has been found that an extensive surgical procedure 
may be considered adequate, providing that the curative 
wide margins of healthy peritumoral tissue are sufficiently 
respected, to ensure that the margins include any skip metas-
tasis with the excision (2,24,25). At present, only two factors 
have been demonstrated to affect the outcome of surgery, 
the extent of the tumor and the margins of excision. Tumors 
>5 cm in size result in a poorer prognosis compared with 
those of smaller dimensions (20). In addition, the majority 
of authors agree that a resection margin of 1 cm is sufficient 
for small and localized sarcomas, and this approach is 
compatible with a conservative surgery. Therefore, in the 
present study, it was decided to treat the chondrosarcoma 
of the breast with surgery, in consideration of the size of 
the lesion, and, in particular, to use a more conservative 
quadrantectomy instead of mastectomy, as a novel surgical 
approach. This approach was chosen with the consideration 
that a greater efficacy has not been proven or demonstrated 
in patients treated with mastectomy in terms of overall and 
disease-free survival compared with patients treated by 
adequate quadrantectomy.
The present treatment strategy was in agreement with a 
previous retrospective study revealing that, for sarcomas of 
the breast, the radical treatment of mastectomy did not offer 
significant survival benefits compared with the wide exci-
sion option of quadrantectomy (20). By contrast, the study 
revealed a more severe prognosis for the patients that under-
went simple lumpectomy. Notably, at the time of writing, a 
novel case report was published in the literature that used a 
similar conservative breast surgery approach (26), supporting 
the present approach of performing quadrantectomy instead 
of mastectomy.
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Table I. Review of the cases of chondrosarcoma of the breast reported in the literature between 2001 and 2013.
First author, year  Age, Tumor site, Method used
(reference) Gender years breast for diagnosis Therapy Follow-up
Errarhay et al, 2013 (7) Female 24 Right Mammography and  Mastectomy NR
    tumorectomy
Mujtaba et al, 2013 (13) Female 40 Right Mammography and CT Mastectomy 
Badyal et al, 2012 (8) Male 80 Right FNAC Mastectomy and axillary  Yes
     lymphadenectomy 
Patterson et al, 2011 (12) Female 52 Left FNAC and core biopsy Mastectomy and RT  Yes
Lakshmikant et al,  Female 42 Left Core biopsy Mastectomy NR
2010 (14)
Bhosale et al, 2010 (15) Female 45 Right Tumorectomy and Mastectomy and axillary Yes
    axillary lymph node lymphadenectomy,
    FNAC RT-CHT
De Padua et al, 2009 (11) Female 56 Right FNAC Mastectomy and RT NR
Gurleyik et al, 2009 (16) Female 52 Right Ultrasonography, Mastectomy and axillary NR
    mammography, FNAC lymphadenectomy
    and tumorectomy 
Gupta et al, 2006 (10) Female 46 Left FNAC Mastectomy NR
Verfaille et al, 2005 (17) Female 77 Right Ultrasonography, Mastectomy NR
    mammography and
    Tru-cut needle biopsy
Gupta et al, 2003 (9) Female 46 Left FNAC Mastectomy, NR
     neoadjuvant CHT, RT
     and lymphadenectomy
CT, computed tomography; FNAC, fine‑needle aspiration cytology; RT, radiotherapy; CHT, chemotherapy; NR, not reported.
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